End-of-day quote
Korea S.E.
23:00:00 13/06/2024 BST
|
5-day change
|
1st Jan Change
|
42,450
KRW
|
-7.31%
|
|
-12.02%
|
-21.39%
|
Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
418,266
|
913,616
|
737,646
|
-
|
-
|
Enterprise Value (EV)
2 |
418.3
|
913.1
|
724.6
|
753.6
|
782.6
|
P/E ratio
|
-20
x
|
-22.5
x
|
-19.5
x
|
-24.2
x
|
-22.1
x
|
Yield
|
-
|
-
|
-
|
-
|
-
|
Capitalization / Revenue
|
-
|
-
|
-
|
61.5
x
|
-
|
EV / Revenue
|
-
|
-
|
-
|
62.8
x
|
-
|
EV / EBITDA
|
-
|
-31.9
x
|
-23.4
x
|
-35.9
x
|
-37.3
x
|
EV / FCF
|
-
|
-29.7
x
|
-21.3
x
|
-27.9
x
|
-25.2
x
|
FCF Yield
|
-
|
-3.36%
|
-4.69%
|
-3.58%
|
-3.96%
|
Price to Book
|
-
|
10.2
x
|
16.5
x
|
48.4
x
|
-43.1
x
|
Nbr of stocks (in thousands)
|
14,698
|
16,919
|
17,377
|
-
|
-
|
Reference price
3 |
28,458
|
54,000
|
42,450
|
42,450
|
42,450
|
Announcement Date
|
23/03/23
|
15/02/24
|
-
|
-
|
-
|
1KRW in Million2KRW in Billions3KRW Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
-
|
-
|
-
|
12
|
-
|
EBITDA
1 |
-
|
-28.64
|
-31
|
-21
|
-21
|
EBIT
1 |
-
|
-31.34
|
-32
|
-22
|
-22
|
Operating Margin
|
-
|
-
|
-
|
-183.33%
|
-
|
Earnings before Tax (EBT)
|
-
|
-
|
-
|
-
|
-
|
Net income
1 |
-19.9
|
-36.85
|
-38
|
-31
|
-34
|
Net margin
|
-
|
-
|
-
|
-258.33%
|
-
|
EPS
2 |
-1,426
|
-2,401
|
-2,173
|
-1,754
|
-1,920
|
Free Cash Flow
3 |
-
|
-30,700
|
-34,000
|
-27,000
|
-31,000
|
FCF margin
|
-
|
-
|
-
|
-225,000%
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/03/23
|
15/02/24
|
-
|
-
|
-
|
1KRW in Billions2KRW3KRW in Million Fiscal Period: December |
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
1 |
-
|
-
|
-
|
16
|
45
|
Net Cash position
1 |
-
|
0.56
|
13
|
-
|
-
|
Leverage (Debt/EBITDA)
|
-
|
-
|
-
|
-0.7619
x
|
-2.143
x
|
Free Cash Flow
2 |
-
|
-30,700
|
-34,000
|
-27,000
|
-31,000
|
ROE (net income / shareholders' equity)
|
-
|
-63.9%
|
-61.1%
|
-104%
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-46.5%
|
-42.1%
|
-35.3%
|
-37.3%
|
Assets
1 |
-
|
79.3
|
90.26
|
87.82
|
91.15
|
Book Value Per Share
3 |
-
|
5,301
|
2,569
|
877.0
|
-985.0
|
Cash Flow per Share
|
-
|
-
|
-
|
-
|
-
|
Capex
1 |
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
23/03/23
|
15/02/24
|
-
|
-
|
-
|
1KRW in Billions2KRW in Million3KRW Last Close Price
42,450
KRW Average target price
80,000
KRW Spread / Average Target +88.46% Consensus |
1st Jan change
|
Capi.
|
---|
| -21.39% | 531M | | +40.80% | 53.67B | | +35.79% | 38.86B | | -8.05% | 38.76B | | -8.98% | 27.27B | | +10.69% | 25.91B | | -16.21% | 20.29B | | +31.00% | 12.78B | | +28.51% | 12.18B | | -1.67% | 11.96B |
Other Biotechnology & Medical Research
|